Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
213 hedge funds and large institutions have $1.49B invested in Cantel Medical Corporation in 2020 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 76 increasing their positions, 66 reducing their positions, and 57 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 66
10% less funds holding
Funds holding: 237 → 213 (-24)
37% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 57
44% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $1.85M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
51% less capital invested
Capital invested by funds: $3.04B → $1.49B (-$1.54B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$39M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$17.4M |
| 3 |
FAM
Fred Alger Management
New York
|
+$14.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$13.1M |
| 5 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$10.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$52.2M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$52M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$49.2M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$34.4M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$18.4M |
CMD Hedge Fund Activity: Q1 2020 in Review
213 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q1 2020, worth a combined $1.49B — down 51% from $3.04B a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of CMD and 36 opened new positions — a net loss of 21 holders — while 66 trimmed existing stakes and 76 added.
The largest buyer was Millennium Management, adding an estimated $39M. The largest seller was Conestoga Capital Advisors, cutting an estimated $52.2M.
- 213 institutional investors held Cantel Medical Corporation (CMD) as of Q1 2020, down from 237 in Q4 2019.
- Funds reported $1.49B of Cantel Medical Corporation stock for Q1 2020, down 51% quarter-over-quarter.
- 36 funds opened new Cantel Medical Corporation positions in Q1 2020 and 57 closed out, a net change of -21 holders.
- The largest Cantel Medical Corporation buyer in Q1 2020 was Millennium Management, an estimated $39M added.
- The largest Cantel Medical Corporation seller in Q1 2020 was Conestoga Capital Advisors, an estimated $52.2M sold.
Based on aggregated 13F filings for Q1 2020.